Compass Therapeutics Inc. (CMPX) — Financial Flexibility Index
Compass Therapeutics Inc. (CMPX) has a Financial Flexibility Index of -0.55x as of June 2026. Free cash flow of $-13.24 Million (operating CF $-13.42 Million minus capex $176.00K) represents -1% of total liabilities ($24.12 Million). Check tangible equity quality of Compass Therapeutics Inc. to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Compass Therapeutics Inc. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Compass Therapeutics Inc. across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Compass Therapeutics Inc. generate cash.
Annual Financial Flexibility Index for Compass Therapeutics Inc. (2018–2025)
Year-by-year free cash flow to debt coverage for Compass Therapeutics Inc.. Explore debt repayment capacity of Compass Therapeutics Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.15x | $-49.12 Million | $-49.14 Million | $22.80 Million | ▲ +27.1% |
| 2024 | -2.95x | $-44.81 Million | $-44.85 Million | $15.17 Million | ▲ +39.3% |
| 2023 | -4.87x | $-40.59 Million | $-40.62 Million | $8.34 Million | ▼ -158.5% |
| 2022 | -1.88x | $-33.91 Million | $-34.12 Million | $18.01 Million | ▼ -42.3% |
| 2021 | -1.32x | $-18.10 Million | $-19.67 Million | $13.68 Million | ▲ +40.7% |
| 2020 | -2.23x | $-26.70 Million | $-26.80 Million | $11.97 Million | ▼ -962.8% |
| 2019 | -0.21x | $-31.27 Million | $-31.74 Million | $148.98 Million | ▲ +0.9% |
| 2018 | -0.21x | $-31.66 Million | $-33.68 Million | $149.40 Million | — |